News and Trends 1 Sep 2022
Study of injection to treat schizophrenia to begin after $3M payment received
A phase 3 clinical trial for an injection to treat patients with schizophrenia has been initiated after a $3 million payment was received by MedinCell. Teva Pharmaceuticals made the decision…